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Abstract 
Background
Low intake of fruits and vegetables (F&V) is a major risk factor for cardiovascular disease (CVD) in the United States. Both mass media campaigns (MMCs) and economic incentives may increase F&V consumption. Few data exist on their comparative effectiveness. 
Objective:
To estimate CVD mortality reductions potentially achievable by price reduction and mass media campaign interventions targeting fruit and vegetable intake in the US population.
Design 
We developed a US IMPACT Food Policy Model to compare three policies targeting F&V intake across US adults from 2015-2030:  national MMC; and national F&V price reductions of 10 and 30%.  We accounted for differences in baseline diets; CVD rates; MMC coverage; MMC duration and declining effects over time. Outcomes included cumulative CVD (coronary heart disease and stroke) deaths prevented or postponed (DPP) and life-years gained (LYG)over the study period,  stratified by age, gender, and race.
Results
A 1-year MMC in 2015 would increase average national F&V consumption by 7% for 1year and prevent approximately 18,600 CVD deaths (95% CI: 17600, 19500) gaining some 280,100 LYGs by 2030. With a 15-year MMC, increased F&V would be sustained yielding a threefold larger reduction (56,100 (52400, 57700)) in CVD deaths. 
In comparison, a 10% decrease in F&V prices would increase F&V consumption by approximately 14%. This would prevent approximately 153,000 deaths (146400, 159200) gaining some 2.51 million LYGs.
For a 30% price decrease, resulting in 42% increase in F&V consumption, corresponding values were 451,900 CVD DPPs (433100, 467500) and 7.3m LYGs.
Effects were similar by gender, with smaller proportional effect and larger absolute effects at older ages.  A 1-year MMC was 35% less effective in preventing CVD deaths in non-Hispanic blacks vs. Whites. In comparison, price reduction policies had equitable proportional effects.
 Conclusions 
Both national MMC and price reduction policies could reduce US CVD mortality, with price reduction being more powerful and sustainable. 



 Introduction
While US cardiovascular disease (CVD) mortality is declining ADDIN EN.CITE (1, 2) due to decreases in population level risk factors and increasing medical treatments(3), CVD remains the leading cause of mortality.  Each year, CVD causes approximately 800,000 deaths and 6 million hospital admissions  ADDIN EN.CITE (2). Coronary heart disease (CHD) alone accounts for approximately 9% of all disability-adjusted life years lost in the US ADDIN EN.CITE (4, 5). This large CVD burden has an associated economic burden, recently predicted to amount to approximately $820 billion by 2030 if current trends continue ADDIN EN.CITE (6).  Furthermore, this CVD burden is unequal by age, sex and race ADDIN EN.CITE (7). Despite declining mortality, race disparities have persisted and in some cases worsened(8).  With such vast health, economic, and equity burdens, CVD remains a challenge and priority for innovative preventive policies. 
Sub-optimal diet is the leading risk factor for cardiovascular mortality and morbidity in the US and globally(9). Appropriately, many leading organizations including the IOM and World Health Organisation have called for governments to adopt and implement evidence-based policies to improve diet(10), in particular intake of fruits and vegetables (F&V) due to their low consumption levels and large associated CVD burdens ADDIN EN.CITE (11-13).  However, the optimal methods to increase population F&V consumption remain unclear.  Potential policy options range from provision of general information, such as via mass media campaigns (MMC), to direct economic incentives, such as subsidies or price reductions for healthy foods. 
Estimates of potential reductions in US CVD mortality, and possible effects upon disparities of dietary policies are limited (14),  whilst quantification of potential health gains of such policies by age, gender, and race are also sparse. Direct comparisons of the health and equity gains of MMC and price reduction policies by age, gender and race are sparser still. Such studies are valuable to understand their potential effectiveness, determine potential varying efficacy, and help inform policy makers facing the large health, economic, and equity burdens of CVD.
We therefore aim to estimate the CVD mortality reductions, life years gained, and subsequent effects upon race disparities that are potentially achievable through MMC and price reduction interventions in the US population from 2015 to 2030 using the US IMPACT Food Policy model. 


Methods
We modelled the comparative effects upon CHD, stroke, and total CVD mortality, life years gained and race disparities through increased F&V consumption by means of a nationwide MMC or price reduction (10% and 30%) from 2015 to 2030. Outputs were stratified by age, gender and race.
Data Sources 
The US population was stratified by age (10-year age groups, 25-85+) and gender using Surveillance, Epidemiology and End Results Program single year population estimates.(15) Population projections were sourced from the US Bureau 2012 National Population Projections.(16) We obtained data on the number of annual CVD deaths (ICD codes: I00-09, I11, I13, I20-I51, I60-69) from 1979 to 2012 from the National Vital Statistics System(17), whilst baseline mortality projections to 2030 using this data, were taken from recent work by our group as described below(8). Baseline fruit and vegetable intake data by age, gender and race were obtained from the nationally-representative National Health and Nutrition Examination Survey (NHANES) 2009-2012(18) using the average of two consecutive 24-hour dietary recalls, whilst projected intake forecasts were derived from NHANES data from 1999-2012(19). Briefly, for each stratum we fitted a survey-weighted linear regression model with survey year as the independent variable and fruit/vegetable intake as the dependent variable. Estimated intakes for 2015-2030 were then estimated for each stratum based on this model using the Stata "margins" command. The standard error of the predicted intakes became less precise the further out-of-sample prediction occurred(20), consistent with out-of-sample prediction in any regression context. Sensitivity analyses were conducted carrying-forward the most recent estimates. For no strata was there evidence of non-linear trends.
Policy scenarios modelled
We modelled three potential policies that could increase F&V consumption in the US. Our comparator was future consumption continuing on current trends through the model described above(19). While the effect of F&V consumption upon CVD mortality is stratified by age and gender ADDIN EN.CITE (21), the effect size of the policy scenarios below (price reduction and MMC) upon F&V consumption are aggregate estimates only although we do include coverage estimates (explained below) to MMC effect size. 
Price reduction
A recent meta-analysis by Afshin et al ADDIN EN.CITE (22) investigated and quantified the effect of change in food price on dietary habits, including F&V. The strength of this meta analyses over previous studies is that it included interventional or prospective observational studies only. This concluded that for every 10% reduction in the price of F&V, consumption increased by 14% (95% uncertainty interval, CI 11, 17%), broadly consistent with other published estimates ADDIN EN.CITE (10, 23). This estimate is valid from 10% to 50% change in price.
To model the effect of an increased consumption of F&V due to a reduction in the price of F&V we used the effect size from the recent meta-analysis of interventional and prospective studies ADDIN EN.CITE (22) discussed above. We applied this effect size to the baseline intake data to estimate resulting intake of F&V. From this point, we ran the model as described below to calculate Deaths Prevented or Postponed. We assumed the effect size applies to all subgroups similarly. Throughout this study we refer to ‘coverage’ as the differing effect size of the policy by age, gender and race. The time-lag from the price reduction policy being implemented to the subsequent effect upon F&V consumption was assumed to be less than a year; hence no time lag is modelled. Finally, we assume a sustained impact of the policy throughout the 15 year period, i.e. no decaying impact of the policy efficacy. 
We modelled two fruit and vegetable price reduction scenarios:
1.	10% price reduction at the point of purchase– a conservative scenario
2.	30% price reduction at the point of purchase – the price reduction achieved through the SNAP pilot programme in Massachusetts ADDIN EN.CITE (24, 25)  
Mass Media Campaign
An update of a further meta-analysis updating previous provisional results(26) investigated and quantified the prospective effect of mass media campaigns (MMC) upon dietary habits, again including F&V.  This suggested that MMC might increase F&V intake approximately 7% (4%, 9%). The methodology to model the effect of MMC on fruit and vegetable consumption was the same as described above for the price reduction scenarios. Using data from the ‘Five a day campaign’(27) we incorporated policy ‘coverage’ estimates stratified by age, gender and race (Supplemental Table 1). Here we used the full effect size 7% (4%, 9%) for the age, gender and race groups with the largest effect size measured in the ‘Five a day campaign’ and apportioned reduced effect size to each other age, gender and race group according to proportional lower observed effect size. Further we included policy ‘decaying impact’ estimates by assuming that the MMC would run for 1 year duration (2015) with a 20% residual effect (minimum 5%, maximum 40%) 5 years later in 2020 (this estimate is further explained in the Supplemental Methods). We modelled linear reduction in effect size from the end of year 1 to year 5, and the residual effect (20%) to persist to 2030. For completeness, we also modelled a less realistic scenario whereby the full effect of the MMC persisted for 15 years duration termed ‘sustained effect’ model, assuming that the campaign will continue to operate at the same intensity over the entire time horizon of the analysis. These results are presented in full in Supplemental Table 2. 
The IMPACT Food Policy Model
The IMPACT Food Policy model is an extension and adaptation of the CHD IMPACT model(28), deployed to the US population in 2007(3), and the IMPACT Food Policy model previously used for modelling potential health gains through adapting healthier food policies in the UK ADDIN EN.CITE (29, 30), Ireland(31) and the US(32) . Full details of the validated IMPACT methodology to calculate deaths prevented or postponed (DPP) and Life Years Gained (LYG) have been described(33). Briefly, using mortality trends (1979-2012) we estimated baseline mortality projections for each year from 2015-2030 for CHD and stroke(8) to provide the number of expected stroke and CHD deaths each year, stratified by age, gender and race.  This estimation is crucial, given the steadily declining CVD mortality rates in the US, to avoid substantial overestimation of potential benefits of any preventive intervention(8).  The IMPACT Food Policy model calculates the expected change in numbers of CHD and stroke deaths attributable to changes in risk factors and treatments. In our analysis, we first estimate the effect of each given policy scenario upon F&V intake. We then used the best evidence of  effect size upon CHD and stroke for both F&V seperately ADDIN EN.CITE (21) stratified by age and gender. This provides the policy scenario effect upon CHD and stroke mortality hence number of deaths in each intervention year. This provides the ‘intervention expected number of deaths’. The difference between the baseline and intervention expected deaths provides the cumulative DPPs from 2015-2030. Then using 2012 life expectancy data for each age and gender group(17) (Supplemental Table 3) we calculated life years gained by multiplying this stratum specific life expectancy data by the generated DPPs.
Probabilistic Sensitivity analyses
We used probabilistic sensitivity analysis to estimate the effect of uncertainty in key model parameters with given input probability distributions. For each policy scenario we performed 10,000 iterations of the full model in R, version 3.2.2(34) providing 95% uncertainty intervals. The key parameters included were effect size of MMC and price reduction upon F&V intake respectively, consumption of F&V, effect size of F&V consumption upon CVD mortality, baseline CVD mortality, ratio of ischaemic:haemorrhagic strokes and years of life lost. Details on parameters and chosen distributions for the Monte Carlo simulation are available in Supplemental Table 4.
Results
Effects of policies on diet
	The change in consumption of F&V varies substantially across the three policy scenarios, and by age, gender and race. A 10% price reduction resulted in an increase of 21.2g (14% above baseline) fruit consumption/day in men aged 55-64 (table 1), compared with a larger 63.6g (42%) increase in fruit consumption/day with a 30% price decrease in the same sub-group. The MMC resulted in just a 0.9g (0.6%) increase in fruits consumption/day in this sub-group. Similar relative increases were observed in vegetable consumption. There was a larger range of increased consumption of F&V across sub-groups under the MMC scenario. For example, young men (25-34) observed a 1.5% (2g/day) increase in fruits consumption, more than double the relative increase in middle aged men outlined above. 
Mortality outcomes
All three policy scenarios would reduce deaths against the baseline of no intervention between 2015-2030. Price reduction scenarios would save a substantially larger number of deaths prevented than a MMC. A 30% price decrease in F&V to the entire US population would yield the greatest mortality savings, reducing total CVD deaths by approximately 6.4% representing some 451900 deaths (95% uncertainty intervals, 433100, 467500) over the period 2015-2030 (table2). This would comprise approximately 236800 (225400, 247200) CHD and 215,100 (200800, 229000) stroke deaths. Prevented CVD deaths would generate 7.3 million LYGs (7000600, 7471500) (table 3). A smaller price decrease in F&V of 10% would still substantially reduce deaths but approximately a third as effective as a 30% price reduction. This scenario would reduce total CVD deaths by 2.2%, some 153300 (146400, 159200) deaths from 2015 to 2030 comprising some 79700 (75900, 83600) CHD and 73200 (68600, 78400) stroke deaths. This would generate 2.5 million LYGs (2371600, 2551100) (table 3). The efficacy of a MMC would vary substantially depending on whether it is a 1-year (decaying impact) or 15-year (sustained effect) campaign. However, both scenarios would yield substantially fewer DPPs than the price reduction scenarios. A nationwide MMC would reduce total CVD deaths by between 0.3 – 0.8% representing 18600 (17600, 19500) to 56100 (52400, 57700) deaths in the 1 year and 15 year MMC respectively (table 2, Supplemental Table 2). A 1 year MMC would generate approximately 280100 LYGs (266900, 291100) (table 3). 
Deaths Prevented or Postponed by Age and Sex
Whilst relative increase in consumption of F&V due to price change would be equal, absolute changes in consumption would be unequal owing to differential baseline consumption. For example, whilst vegetable consumption in men 65-74 and 75+ rose by 14% uniformly in the 10% price reduction scenario, this resulted in a 27g/day (ie from 191.1g in 2015 to 219.8g in 2030) and 23.4g (ie from 169.9g in 2015 to 190.4g in 2030) absolute increase in consumption respectively in 2030 (table 1). The largest residual increase in fruits consumption compared with 2030 baseline intake would be 1.5% (2.0g/day) in young (25-34) men. This was some 2.5 times larger than the modest increase (0.6%, 0.9g/day) in consumption seen in middle aged (55-64) men (table 1). This difference between the policy scenarios is consistent with the variation of efficacy of each policy by sub-group highlighted in the methods.
The variation in absolute change in F&V consumption, combined with baseline mortality resulted in varying absolute and relative reduction in deaths by age and gender(table 4). Generally, DPPs would increase with age and are greater in men than women. Across all three policies, largest absolute mortality gains would be seen in the oldest age group (75+) of women over the period 2015-2030 (table 4) where some 120900 (110200, 131600) deaths would be averted with a 30% F&V price representing a reduction of approximately 5.1% compared to 4.2% in the same age group in men. The largest relative reductions in CVD mortality however would be seen in younger groups in the 30% F&V price reduction scenario. Young women (25-34) would observe a reduction in mortality of some 16.1%, whilst 35-44 year old women would see a similar reduction of 13.8% representing some 4400 (3900, 4800) deaths. A similar pattern was seen in the 10% price reduction scenario. Whilst mortality reductions in the MMC scenario would be substantially lower, largest relative gains would be in the young age groups (men and women, 25-34) who are most receptive to the media campaign. These groups would see a reduction in CVD mortality of approximately 0.7-0.8%, representing just 130 (110-150) and 59 (51-68) deaths in men and women respectively. If the MMC was sustained over the 15-year period this would prevent three times as many deaths (approximately 18,600) than the model assuming a decay in impact (table 2, Supplemental Table 2).
Effects on Race Disparities
	Potential averted deaths due to MMC or price reduction policies (10% and 30%) would vary significantly by race (figure 1). A 10% price decrease would be approximately equitable across race groups with non-Hispanic whites observing a 1.86% reduction in CVD mortality over the 15 year period comparing with 1.83% reduction, just 1.6% less in non-Hispanic blacks. A 30% price reduction in fruits & vegetables would be similarly equitable resulting in CVD mortality reductions of 5.51% and 5.41% in non-Hispanic whites and non-Hispanic blacks respectively. In contrast, a MMC would be one twentieth as equitable. The MMC would result in a 0.23% reduction in CVD mortality in non-Hispanic whites compared to just 0.15% in non-Hispanic blacks. Much of this 35% reduced effectiveness in non-Hispanic blacks was attributed to lower coverage and receptiveness to the campaign (Supplemental Table 1). Hispanic groups would observe larger reductions in CVD mortality in both price reduction scenarios (2.35% and 6.90% in 10% and 30% price reduction respectively), however some 75% lower reduction (0.06%) in CVD mortality in the MMC scenario when compared to non-Hispanic whites. 
Discussion
	This is the first study to our knowledge to compare potential effects upon cardiovascular mortality of F&V MMCs and price reduction policies from 2015-2030 stratified by age, gender and race in the US. Policies effectively increasing fruit and vegetable consumption could powerfully reduce CVD mortality in the US. Whilst all three policies would result in reductions in deaths by 2030, the magnitude and rate of such reductions differed substantially. A 30% price reduction in F&V alone could reduce CVD mortality from 2015-2030 by approximately 6.4%, saving approximately 451900 deaths during this period. These gains could be over twenty times greater than mortality savings from national mass media campaigns. 
One key contributor to the magnitude of the differential mortality reduction between these different approaches is the decaying impact of media campaigns. In this modelling study, we assumed (not unreasonably) that a year-long media campaign might see a subsequent decline in effectiveness over time, with perhaps just a 20% residual effect 5 years later.  If the effect was sustained however this would be approximately three times as effective in reducing mortality over the 15-year period. Regardless of the MMC duration, price reduction policies were more powerful and equitable. 
Policy Implications
Our study suggests that population-wide fiscal policies would be more effective over a longer period. Price reduction policies might be more equitable than MMC amongst race groups, using  data describing varying coverage estimates from previous nationwide campaigns(27) to model differential efficacy of the media campaign on age, gender and race groups, however further research is needed to confirm the equitability of price reduction policies in F&V specifically. These potential differences become even larger when examining age and gender more closely.  In the price reduction scenarios, much of the difference in reduced CVD mortality was due to variance in baseline F&V consumption:  assuming a uniform proportional increase in consumption would therefore widen the disparity between those consuming most and least F&V.  Poor intake of F&V is a strong risk factor for CHD, stroke and common cancers, and intake is often lowest in the most deprived groups in society, thus widening disparities.  Public health strategies can aim to improve the environment (structural policies) or facilitate behaviour change in individuals (“agentic” policies)(35).  The findings of our study are consistent with this notion, with nationwide price reduction policies potentially being more equitable than the media campaign attempting to change individual behaviour. 
F&V consumption has increased in the US over the past decade(18) and is projected to increase further(19).  However, consumption remains substantially below the recommended amounts of 2.5 vegetable (cups) and 2 fruit (cups) a day ADDIN EN.CITE (36).  The findings of this study have important implications for crafting specific price and incentive policy approaches to increase F&V access. F&V have high production costs because they have limited storage time, they often have to be transported with temperature control, they typically have to be hand-picked or cannot be harvested completely mechanized, and certain crops are especially susceptible to adverse weather(37). The ultimate price that consumers pay for F&V is affected by policies and practices that have impact across the entire food production system(38), including international trade agreements, immigration law, imports/exports as well as the technology that is used to harvest and transport fragile crops across the globe. Embedding pricing incentives systematically within government feeding programs such as the Supplemental Nutrition Assistance Program (SNAP) could increase the purchase and consumption of F&V within low-income populations.  These benefits could be extended if Electronic Benefits Transfer was integrated into all Farmers Markets, allowing recipients to authorize transfer of their government benefits to the retailers through retail channels of all sizes (from local farmers' markets all the way up to large scale retailers). Other pricing-related policy approaches could extend to growers, providing them with more accessible crop insurance, some agricultural subsidies for growing specialty crops, or offering government incentives to diversify crops across base acres of land. Thus,  a system-wide approach to price strategies might be necessary to effectively increase broader access to fruit and vegetables(39). 
	This study has strengths. This is the first study to quantify and compare potential health gains of F&V MMC and price reduction policies which could be of great use to policy makers. We used nationally representative data sets encompassing the US adult (25+) population ADDIN EN.CITE (15, 17, 40). Further, we used comprehensive meta analyses ADDIN EN.CITE (21) for effect sizes of F&V upon CVD mortality and of each given policy upon F&V intake within the US population ADDIN EN.CITE (22, 26) .  Stratifying potential policy effects upon race disparities in the US of these policies is an additional strength. Further, our health outcomes analysis assumes continuing recent declines in CVD mortality(8) rather than more conventional methods which simply use a static baseline. If future mortality plateaus, or even increases, mortality savings through the modelled policy scenarios would be even greater.   
This study also has limitations. Both the effect of F&V upon CHD and stroke mortality, alongside the effect upon consumption of each given policy are taken from comprehensive meta analysis, thus are imperfect estimates ADDIN EN.CITE (14, 21, 22, 26)   The meta analyses we use (22) provides the same elasticity for fruits, and vegetables however other estimates find differences in their respective elasticities (10). Further, whilst this meta-analysis did not find heterogeneity by age, nor assess by sex or race, the relatively small number of studies included means we cannot conclude that there is no heterogeneity, just that none was found in this study. Our method of projecting dietary trends is based on 14 years of data, and this might not be enough to detect potential non-linearity in the trend, however we incorporated the uncertainty in the trend estimation in the probabilistic sensitivity analysis. When calculating LYGs, using disease sub-group (CHD subgroup, stroke) specific median survivals are desirable, as with previous work in the UK ADDIN EN.CITE (33, 41). However, the age specific life expectancy data used in our study offer a reasonable proxy. We assumed a short lag time between policy implementation and reductions in CVD mortality. However, evidence consistently supports this assumption(42). Whilst we incorporated coverage estimations by age, gender and race for the MMC using data from the nation-wide ‘5 a day campaign’(27), scarce data exists regarding decaying impact of media campaigns. We therefore approximated 20% residual effect after 5 years with wide uncertainty parameters (5-40%), whilst including potential mortality savings of a ‘prolonged’ 15-year media campaign in a sensitivity analysis. We did not account for differing price elasticity of demand for F&V by age, gender and race, which could under-estimate the effects of such policies upon reducing disparities.  Similarly, we did not account for a substitution effects of increasing F&V consumption. However, the meta analyses deriving model parameters present observed effects, accounting for average actual population substitutes and compliments. Focused efforts to encourage specific substitutions could make such interventions even more effective.  Further research addressing the cost effectiveness of such potential food policies is therefore warranted.
Conclusions
Increasing the consumption of F&V is an achievable and important target for public health policy. One which could substantially reduce US CVD mortality.  Furthermore, compared with national mass media campaigns, price reduction policies of 10% or 30% would be far more powerful and sustainable. Decisive action is now indicated, prioritising the most effective and cost-effective policy options. 
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Tables
Table 1. Baseline consumption of fruits and vegetables in 2015 and 2030 (current trends) and achieved consumption associated with modelled policy options stratified by age and gender. Numbers in parenthesis are 95% uncertainty intervals. Consumption reported as g/day. 
Fruits	 	2015 Baseline	2030 Baseline	2030 Price decrease by 10%	2030 Price decrease by 30%	2030 MMC- decaying impact
Men	25-34	102.3 (86.0, 121.5)	136.1 (99.2, 182.9)	155.2 (112.3, 210.7)	193.3 (139.2, 261.9)	138.1 (100.7, 183.9)
	35-44	82.2 (66.0, 101.0)	83.0 (47.6, 129.6)	94.6 (54.1, 158.6)	117.9 (65.0, 192.1)	84.0 (48.8, 139.1)
	45-54	126.6 (100.7, 158.9)	150.7 (92.5, 223.7)	171.8 (106.3, 262.2)	214.0 (130.9, 325.3)	152.1 (94.0, 230.5)
	55-64	130.3 (109.7, 152.2)	151.3 (103.0, 215.0)	172.5 (119.5, 235.2)	214.9 (150.2, 294.1)	152.2 (103.1, 209.7)
	65-74	120.2 (97.6, 149.1)	110.6 (62.7, 175.7)	126.1 (72.7, 200.9)	157.0 (88.5, 261.5)	112.0 (60.8, 189.5)
	75+	129.4 (112.1, 150.7)	115.9 (77.1, 170.7)	132.2 (84.1, 194.9)	164.6 (104.6, 242.7)	117.4 (74.1, 176.7)
Women	25-34	115.6 (99.6, 132.0)	153.0 (114.2, 198.3)	174.5 (132.7, 229.0)	217.3 (163.3, 280.5)	154.8 (118.3, 198.8)
	35-44	107.8 (86.7, 130.1)	129.9 (85.1, 190.4)	148.1 (97.9, 215.0)	184.4 (117.5, 280.1)	131.2 (84.7, 195.8)
	45-54	123.8 (107.2, 143.1)	139.9 (98.2, 195.0)	159.4 (112.3, 222.3)	198.6 (142.9, 266.6)	140.9 (104.5, 193.1)
	55-64	143.8 (124.9, 164.5)	164.4 (111.4, 223.5)	187.4 (131.8, 257.6)	233.4 (161.1, 318.7)	165.2 (115.3, 230.6)
	65-74	151.7 (128.9, 177.1)	162.4 (111.3, 232.4)	185.1 (123.3, 264.3)	230.6 (161.3, 323.9)	164.1 (111.1, 239.9)
	75+	140.6 (124.2, 159.5)	139.7 (96.8, 197.1)	159.3 (112.0, 228.4)	198.4 (136.8, 292.6)	141.2 (97.2, 199.9)
Vegetables	25-34	163.9 (148.3, 180.4)	167.7 (128.5, 215.4)	191.2 (146.3, 244.6)	238.1 (181.0, 303.4)	170.0 (133.4, 217.6)
 	35-44	179.0 (162.8, 196.9)	185.2 (142.8, 230.8)	211.2 (162.8, 273.9)	263.0 (205.9, 334.7)	187.5 (148.0, 234.6)
 	45-54	174.5 (152.9, 200.5)	175.6 (120.1, 250.5)	200.2 (140.0, 280.7)	249.4 (176.3, 343.2)	177.3 (124.3, 244.1)
Men	55-64	180.0 (163.6, 197.0)	184.8 (146.3, 228.9)	210.7 (165.1, 260.5)	262.5 (208.2, 330.2)	185.9 (149.7, 229.9)
 	65-74	191.1 (164.3, 219.4)	192.8 (135.2, 257.4)	219.8 (156.2, 300.8)	273.8 (190.3, 375.7)	195.2 (141.2, 261.1)
 	75+	169.9 (150.0, 193.6)	167.0 (120.1, 224.3)	190.4 (136.8, 258.3)	237.1 (165.0, 326.7)	169.1 (122.3, 224.1)
Women	25-34	173.5 (152.7, 196.7)	163.6 (117.1, 225.6)	186.4 (132.9, 264.6)	232.2 (161.0, 334.6)	165.5 (117.7, 231.1)
	35-44	180.1 (157.2, 202.5)	177.1 (126.0, 243.5)	201.9 (143.3, 278.6)	251.5 (180.5, 341.2)	178.9 (129.5, 241.8)
	45-54	212.4 (185.3, 238.4)	221.9 (166.8, 288.3)	253.0 (187.5, 331.8)	315.1 (233.4, 402.6)	223.6 (167.1, 288.3)
	55-64	212.9 (185.4, 239.5)	211.4 (158.2, 283.0)	241.0 (176.8, 319.4)	300.2 (216.0, 392.9)	212.5 (157.2, 279.0)
	65-74	202.7 (183.5, 224.6)	190.2 (144.1, 251.5)	216.9 (163.9, 283.7)	270.1 (204.1, 357.7)	192.2 (142.2, 252.8)
	75+	169.8 (151.9, 188.1)	159.0 (115.6, 210.9)	181.3 (135.9, 234.8)	225.8 (170.2, 292.6)	160.7 (120.4, 211.8)
Baseline number of deaths cumulative from 2015-2030. MMC ‘decaying impact’ models 1 year MMC, ‘sustained effect’ models 15 year MMC. 


Table 2. Total cumulative expected deaths from CVD for 2015-2030 and reductions associated with each policy scenario. Baseline expected deaths, reductions in deaths (95% uncertainty intervals), and % reduction in CVD mortality. Stratified by CVD subtype and gender. Results are rounded to the nearest 100.
 	Baseline	Price decrease by 10%	Price decrease by 30%	MMC - decaying impact	MMC - sustained effect
CHD	5 051 300 
(4 930 100, 5 187 800)	79 700 
(75 900, 83 600)	236 800 
(225 400, 247 200)	9 600 
(9 000, 10 200)	28 700 
(26 700, 29 500)
		1.6%	4.7%	0.2%	0.6%
Men	2 900 600 
(2 823 000, 2 995 200)	47 100 
(44 200, 50 000)	139 800 
(131 100, 147 600)	6 000 
(5 500, 6 500)	17 900 
(16 300, 18 700)
		1.6%	4.8%	0.2%	0.6%
Women	2 150 800 
(2 055 800, 2 253 300)	32 600 
(30 200, 35 100)	97 000 
(90 700, 104 400)	3 700 
(3 300, 4 100)	10 900 
(9 800, 11 500)
		1.5%	4.5%	0.2%	0.5%
Stroke	2 011 600 
(1 900 300, 2 135 100)	73 200 
(68 600, 78 400)	215 100 
(200 800, 229 000)	9 000 
(8 300, 9 600)	27 300 
(24 700, 29 100)
		3.6%	10.7%	0.4%	1.4%
Men	862 400 
(773 700, 970 400)	32 000 
(28 400, 36 200)	93 800 
(83 400, 105 400)	4 200 
(3 800, 4 700)	12 900 
(11 100, 14 500)
		3.7%	10.9%	0.5%	1.5%
Women	1 149 200 
(1 085 500, 1 214 100)	41 300 
(37 900, 44 600)	121 200 
(111 500, 130 700)	4 700 
(4 300, 5 200)	14 400 
(12 900, 15 500)
		3.6%	10.5%	0.4%	1.3%
CVD	7 062 900 
(6 890 400, 7 244 100)	153 000 
(146 400, 159 200)	451 900 
(433 100, 467 500)	18 600 
(17 600, 19 500)	56 100 
(52 400, 57 700)
		2.2%	6.4%	0.3%	0.8%
Men	3 762 900 
(3 636 400, 3 908 800)	79 000 
(74 600, 84 200)	233 700 
(219 500, 246 200)	10 200 
(9 500, 10 800)	30 800 
(28 200, 32 400)
		2.1%	6.2%	0.3%	0.8%
Women	3 300 000 
(3 189 300, 3 410 500)	73 900 
(69 800, 78 000)	218 300 
(206 100, 230 100)	8 400 
(7 800, 9 100)	25 300 
(23 200, 26 400)
		2.2%	6.6%	0.3%	0.8%

Baseline number of deaths cumulative from 2015-2030. MMC ‘decaying impact’ models 1 year MMC, ‘sustained effect’ models 15 year MMC. 



Table 3. Cumulative Life Years Gained for 2015-2030 with each policy option. Numbers in parenthesis are 95% uncertainty intervals . Stratified by CVD subtype and gender. Results are rounded to the nearest 100.
 	Price decrease by 10%	Price decrease by 30%	MMC - decaying impact
CHD	1 363 900
(1 301 000, 1 424 600)	4 044 500
(3 869 400, 4 197 000)	152 800
(143 900, 161 500)
Men	823 200
(776 000, 871 200)	2 440 900
(2 297 100, 2 571 200)	97 200
(89 600, 104 400)
Women	540 700
(507 500, 579 300)	1 603 600
(1 504 500, 1 699 600)	55 600
(50 800, 60 500)
Stroke	1 099 500
(1 038 000, 1 160 800)	3 214 500
(3 026 500, 3 377 100)	127 300
(118 700, 135 400)
Men	484 000
(438 200, 538 400)	1 414 700
(1 285 900, 1 559 100)	60 400
(54 400, 66 100)
Women	615 600
(573 900, 653 700)	1 799 900
(1 677 000, 1 918 600)	66 900
(61 200, 72 600)
CVD	2 463 400
(2 371 600, 2 551 100)	7 259 000
(7 000 600, 7 471 500)	280 100
(266 900, 291 100)
Men	1 307 200
(1 240 300, 1 378 600)	3 855 500
(3 652 600, 4 045 100)	157 600
(147 900, 166 700)
Women	1 156 300
(1 100 200, 1 208 800)	3 403 400
(3 241 900, 3 554 900)	122 500
(114 600, 130 100)

Baseline number of deaths cumulative from 2015-2030. MMC ‘decaying impact’ models 1 year MMC. 


 Table 4. Expected deaths from CVD from 2015-2030 and cumulative absolute deaths prevented or postponed 2015-2030 associated with each policy option, by age and gender. Baseline expected deaths, reduction in deaths (95% uncertainty intervals), and % reduction in CVD mortality. Results rounded to nearest 100, nearest 10 (<1000) and no rounding (<100). 
 	Baseline	Price decrease by 10%	Price decrease by 30%	MMC - decaying impact
Men 25-34	18 600
(17 300, 20 100)	810
(700, 950)	2 400
(2 100, 2 800)	130
(110, 150)
		4.4%	12.8%	0.7%
35-44 	87 400
(82 600, 92 600)	3 000
(2 700, 3 400)	8 800
(7 800, 9 900)	420
(360, 470)
		3.4%	10.1%	0.5%
45-54 	239 600
(227 900, 251 500)	8 400
(7 600, 9 300)	24 700
(22 100, 27 400)	930
(810, 1 060)
		3.5%	10.3%	0.4%
55-64 	518 200
(495 700, 541 800)	16 200
(14 500, 17 800)	47 800
(42 900, 52 900)	1 200
(1 000, 1 400)
		3.1%	9.2%	0.2%
65-74 	854 700
(811 400, 908 100)	21 400
(19 100, 24 300)	63 200
(56 400, 70 600)	3 200
(2 800, 3 600)
		2.5%	7.4%	0.4%
75+ 	2 044 600
(1 938 300, 2 173 700)	29 200
(25 900, 33 000)	86 900
(77 000, 97 900)	4 400
(3 900, 4 900)
		1.4%	4.2%	0.2%
Women 25-34	7 900
(7 400, 8 600)	440
(390, 490)	1 300
(1 100, 1 400)	59
(51, 68)
		5.6%	16.1%	0.8%
35-44	32 000
(30 400, 34 000)	1 500
(1 400, 1 700)	4 400
(3 900, 4 800)	180
(150, 200)
		4.7%	13.8%	0.6%
45-54	99 500
(94 800, 104 700)	4 400
(4 000, 4 800)	12 800
(11 600, 14 000)	410
(360, 460)
		4.4%	12.9%	0.4%
55-64	266 300
(253 400, 280 600)	10 300
(9 300, 11 200)	30 100
(27 400, 32 800)	620
(540, 700)
		3.8%	11.3%	0.2%
65-74	517 500
(489 800, 548 400)	16 600
(15 000, 18 300)	48 900
(44 500, 53 300)	2 000
(1 800, 2 200)
		3.2%	9.4%	0.4%
75+	2 376 700
(2 265 500, 2 486 000)	40 700
(37 300, 44 400)	120 900
(110 200, 131 600)	5 100
(4 600, 5 800)
		1.7%	5.1%	0.2%
Baseline number of deaths cumulative from 2015-2030. MMC ‘decaying impact’ models 1 year MMC, ‘sustained effect’ models 15 year MMC. 
 Figure 1. Relative reduction in CVD mortality by 2030 through a 15-year mass media campaign, 10% and 30% price decrease in fruits and vegetables. Stratified by race – Hispanic (HISP), non-Hispanic Black (NHB) and non-Hispanic white (NHW). 



